{
    "output": [
        [
            "Teva Pharmaceutical Industries Ltd.",
            "ORG",
            "Announce",
            "Use of TRISENOX",
            "PRODUCT"
        ],
        [
            "Teva Pharmaceutical Industries Ltd.",
            "ORG",
            "Operate_In",
            "Pharmaceutical Industry",
            "SECTOR"
        ],
        [
            "U.S. Food and Drug Administration (FDA)",
            "ORG/GOV",
            "Approve",
            "Use of TRISENOX",
            "PRODUCT"
        ],
        [
            "TRISENOX",
            "PRODUCT",
            "Treat",
            "Adults with newly-diagnosed low-risk acute promyelocytic leukemia (APL)",
            "CONCEPT"
        ],
        [
            "TRISENOX",
            "PRODUCT",
            "Contain",
            "Arsenic trioxide",
            "COMP"
        ],
        [
            "TRISENOX",
            "PRODUCT",
            "Combine",
            "with tretinoin",
            "PRODUCT"
        ],
        [
            "Teva Pharmaceutical Industries Ltd.",
            "ORG",
            "Produce",
            "TRISENOX",
            "PRODUCT"
        ],
        [
            "TRISENOX",
            "PRODUCT",
            "Impact",
            "Cancer Care",
            "CONCEPT"
        ],
        [
            "TRISENOX",
            "PRODUCT",
            "Reinforce",
            "Current practice guidelines",
            "CONCEPT"
        ],
        [
            "National Comprehensive Cancer Network",
            "ORG",
            "Establish",
            "Current practice guidelines",
            "CONCEPT"
        ]
    ]
}